Publications by authors named "A Satlin"

Claim this Profile
D
Design considerations for C9orf72 disease prevention trials.
Michael Benatar, Adam M Staffaroni, Joanne Wuu, Michael P McDermott, Melanie Quintana, Andrew Satlin

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
Trisha Suppes, Suresh Durgam, Susan G Kozauer, Richard Chen, Hassan D Lakkis, Andrew Satlin

Bipolar Disord· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Joseph R Calabrese, Suresh Durgam, Andrew Satlin, Kimberly E Vanover, Robert E Davis

Am J Psychiatry· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials.
John M Kane, Suresh Durgam, Andrew Satlin, Kimberly E Vanover, Richard Chen

Int Clin Psychopharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure.
Nisha A Gilotra, Adam D DeVore, Thomas J Povsic, Allison G Hays, Virginia S Hahn, Andrew Satlin

Circ Heart Fail· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis